Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab for Acute Exacerbations of Asthma and COPD
NCT04098718Phase 2Unknown
- Sponsor
- University of Oxford
- Start
- Mar 2021
- Primary completion
- Feb 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of benralizumab in asthma, chronic obstructive pulmonary disease (COPD), sponsored by University of Oxford. Status: unknown.
02
Drugs
benralizumab
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04098718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04098718.